ArticleDiscover oncology2025

Evaluating the safety and feasibility of allogeneic NK cell infusion in high-risk lymphoma patients post-autologous stem cell transplantation.

Shirin Tavakoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.